International research networks in viral structural proteomics : Again, lessons from SARS
Identifieur interne : 000277 ( PascalFrancis/Corpus ); précédent : 000276; suivant : 000278International research networks in viral structural proteomics : Again, lessons from SARS
Auteurs : Bruno Canard ; Jeremiah S. Joseph ; Peter KuhnSource :
- Antiviral research [ 0166-3542 ] ; 2008.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Emerging and re-emerging pathogens and bioterror threats require an organized and coherent response from the worldwide research community to maximize available resources and competencies with the primary goals to understand the pathogen and enable intervention. In 2001, the Structural Proteomics In Europe (SPINE) project prototyped the pan-viral structural genomic approach, and the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 accelerated the concept of structural characterization of all proteins from a viral proteome and the interaction with their host partners. Following that approach, in 2004 the center for Functional and Structural Proteomics for SARS-CoV related proteins was initiated as part of the US NIH NIAID proteomics resource centers. Across worldwide efforts in Asia, Europe and America, the international research teams working on SARS-CoV have now determined experimental structural information for 45% of the SARS-CoV proteins and 53% of all its soluble proteins. This data is fully available to the scientific community and is providing an unprecedented level of insight to this class of RNA viruses. The efforts and results by the international scientific community to the SARS outbreak are serving as an example and roadmap of a rapid response using modem research methods.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 08-0296266 INIST |
---|---|
ET : | International research networks in viral structural proteomics : Again, lessons from SARS |
AU : | CANARD (Bruno); JOSEPH (Jeremiah S.); KUHN (Peter); BRAY (Mike); NEYTS (Johan) |
AF : | Architecture Et Fonction Des Macromolécules Biologiques UMR 6098, CNRS, Universités Aix-Marseille I & II, Case 932, 163 Avenue de Luminy/13288 Marseille/France (1 aut.); Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265/La Jolla, CA 92037/Etats-Unis (2 aut., 3 aut.); Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health/Bethesda, MD/Etats-Unis (1 aut.); Rega Institute for Medical Research, Catholic University Leuven/Leuven/Belgique (2 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Antiviral research; ISSN 0166-3542; Coden ARSRDR; Pays-Bas; Da. 2008; Vol. 78; No. 1; Pp. 47-50; Bibl. 3/4 p. |
LA : | Anglais |
EA : | Emerging and re-emerging pathogens and bioterror threats require an organized and coherent response from the worldwide research community to maximize available resources and competencies with the primary goals to understand the pathogen and enable intervention. In 2001, the Structural Proteomics In Europe (SPINE) project prototyped the pan-viral structural genomic approach, and the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 accelerated the concept of structural characterization of all proteins from a viral proteome and the interaction with their host partners. Following that approach, in 2004 the center for Functional and Structural Proteomics for SARS-CoV related proteins was initiated as part of the US NIH NIAID proteomics resource centers. Across worldwide efforts in Asia, Europe and America, the international research teams working on SARS-CoV have now determined experimental structural information for 45% of the SARS-CoV proteins and 53% of all its soluble proteins. This data is fully available to the scientific community and is providing an unprecedented level of insight to this class of RNA viruses. The efforts and results by the international scientific community to the SARS outbreak are serving as an example and roadmap of a rapid response using modem research methods. |
CC : | 002B02S05; 002B05C02C |
FD : | Réseau international; Protéomique; Relation structure activité; Syndrome respiratoire aigu sévère; Virus syndrome respiratoire aigu sévère; Génomique; Virus à ARN; Recherche et développement; Antiviral; Projet Vizier |
FG : | Virose; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Pathologie de l'appareil respiratoire; Pathologie des poumons |
ED : | International network; Proteomics; Structure activity relation; Severe acute respiratory syndrome; Severe acute respiratory syndrome virus; Genomics; RNA virus; Research and development; Antiviral |
EG : | Viral disease; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Respiratory disease; Lung disease |
SD : | Red internacional; Proteómica; Relación estructura actividad; Síndrome respiratorio agudo severo; Severe acute respiratory syndrome virus; Genómica; Virus con RNA; Investigación desarrollo; Antiviral |
LO : | INIST-18839.354000172642930040 |
ID : | 08-0296266 |
Links to Exploration step
Pascal:08-0296266Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">International research networks in viral structural proteomics : Again, lessons from SARS</title>
<author><name sortKey="Canard, Bruno" sort="Canard, Bruno" uniqKey="Canard B" first="Bruno" last="Canard">Bruno Canard</name>
<affiliation><inist:fA14 i1="01"><s1>Architecture Et Fonction Des Macromolécules Biologiques UMR 6098, CNRS, Universités Aix-Marseille I & II, Case 932, 163 Avenue de Luminy</s1>
<s2>13288 Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Joseph, Jeremiah S" sort="Joseph, Jeremiah S" uniqKey="Joseph J" first="Jeremiah S." last="Joseph">Jeremiah S. Joseph</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265</s1>
<s2>La Jolla, CA 92037</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kuhn, Peter" sort="Kuhn, Peter" uniqKey="Kuhn P" first="Peter" last="Kuhn">Peter Kuhn</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265</s1>
<s2>La Jolla, CA 92037</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0296266</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0296266 INIST</idno>
<idno type="RBID">Pascal:08-0296266</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000277</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">International research networks in viral structural proteomics : Again, lessons from SARS</title>
<author><name sortKey="Canard, Bruno" sort="Canard, Bruno" uniqKey="Canard B" first="Bruno" last="Canard">Bruno Canard</name>
<affiliation><inist:fA14 i1="01"><s1>Architecture Et Fonction Des Macromolécules Biologiques UMR 6098, CNRS, Universités Aix-Marseille I & II, Case 932, 163 Avenue de Luminy</s1>
<s2>13288 Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Joseph, Jeremiah S" sort="Joseph, Jeremiah S" uniqKey="Joseph J" first="Jeremiah S." last="Joseph">Jeremiah S. Joseph</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265</s1>
<s2>La Jolla, CA 92037</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kuhn, Peter" sort="Kuhn, Peter" uniqKey="Kuhn P" first="Peter" last="Kuhn">Peter Kuhn</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265</s1>
<s2>La Jolla, CA 92037</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Genomics</term>
<term>International network</term>
<term>Proteomics</term>
<term>RNA virus</term>
<term>Research and development</term>
<term>Severe acute respiratory syndrome</term>
<term>Severe acute respiratory syndrome virus</term>
<term>Structure activity relation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Réseau international</term>
<term>Protéomique</term>
<term>Relation structure activité</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Génomique</term>
<term>Virus à ARN</term>
<term>Recherche et développement</term>
<term>Antiviral</term>
<term>Projet Vizier</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Emerging and re-emerging pathogens and bioterror threats require an organized and coherent response from the worldwide research community to maximize available resources and competencies with the primary goals to understand the pathogen and enable intervention. In 2001, the Structural Proteomics In Europe (SPINE) project prototyped the pan-viral structural genomic approach, and the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 accelerated the concept of structural characterization of all proteins from a viral proteome and the interaction with their host partners. Following that approach, in 2004 the center for Functional and Structural Proteomics for SARS-CoV related proteins was initiated as part of the US NIH NIAID proteomics resource centers. Across worldwide efforts in Asia, Europe and America, the international research teams working on SARS-CoV have now determined experimental structural information for 45% of the SARS-CoV proteins and 53% of all its soluble proteins. This data is fully available to the scientific community and is providing an unprecedented level of insight to this class of RNA viruses. The efforts and results by the international scientific community to the SARS outbreak are serving as an example and roadmap of a rapid response using modem research methods.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0166-3542</s0>
</fA01>
<fA02 i1="01"><s0>ARSRDR</s0>
</fA02>
<fA03 i2="1"><s0>Antivir. res.</s0>
</fA03>
<fA05><s2>78</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>International research networks in viral structural proteomics : Again, lessons from SARS</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Treatment of highly pathogenic RNA viral infections</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>CANARD (Bruno)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JOSEPH (Jeremiah S.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KUHN (Peter)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>BRAY (Mike)</s1>
<s9>limin.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>NEYTS (Johan)</s1>
<s9>limin.</s9>
</fA12>
<fA14 i1="01"><s1>Architecture Et Fonction Des Macromolécules Biologiques UMR 6098, CNRS, Universités Aix-Marseille I & II, Case 932, 163 Avenue de Luminy</s1>
<s2>13288 Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265</s1>
<s2>La Jolla, CA 92037</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Rega Institute for Medical Research, Catholic University Leuven</s1>
<s2>Leuven</s2>
<s3>BEL</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA20><s1>47-50</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18839</s2>
<s5>354000172642930040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>3/4 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0296266</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Antiviral research</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Emerging and re-emerging pathogens and bioterror threats require an organized and coherent response from the worldwide research community to maximize available resources and competencies with the primary goals to understand the pathogen and enable intervention. In 2001, the Structural Proteomics In Europe (SPINE) project prototyped the pan-viral structural genomic approach, and the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 accelerated the concept of structural characterization of all proteins from a viral proteome and the interaction with their host partners. Following that approach, in 2004 the center for Functional and Structural Proteomics for SARS-CoV related proteins was initiated as part of the US NIH NIAID proteomics resource centers. Across worldwide efforts in Asia, Europe and America, the international research teams working on SARS-CoV have now determined experimental structural information for 45% of the SARS-CoV proteins and 53% of all its soluble proteins. This data is fully available to the scientific community and is providing an unprecedented level of insight to this class of RNA viruses. The efforts and results by the international scientific community to the SARS outbreak are serving as an example and roadmap of a rapid response using modem research methods.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02S05</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05C02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Réseau international</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>International network</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Red internacional</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Protéomique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Proteomics</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Proteómica</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Relation structure activité</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Structure activity relation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Relación estructura actividad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Virus syndrome respiratoire aigu sévère</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Génomique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Genomics</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Genómica</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Virus à ARN</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>RNA virus</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Virus con RNA</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Recherche et développement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Research and development</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Investigación desarrollo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>10</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>10</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Projet Vizier</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Pathologie des poumons</s0>
<s5>38</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>189</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 08-0296266 INIST</NO>
<ET>International research networks in viral structural proteomics : Again, lessons from SARS</ET>
<AU>CANARD (Bruno); JOSEPH (Jeremiah S.); KUHN (Peter); BRAY (Mike); NEYTS (Johan)</AU>
<AF>Architecture Et Fonction Des Macromolécules Biologiques UMR 6098, CNRS, Universités Aix-Marseille I & II, Case 932, 163 Avenue de Luminy/13288 Marseille/France (1 aut.); Department of Cell Biology, The Scripps Research Institute, 10550 N Torrey Pines Road, CB265/La Jolla, CA 92037/Etats-Unis (2 aut., 3 aut.); Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health/Bethesda, MD/Etats-Unis (1 aut.); Rega Institute for Medical Research, Catholic University Leuven/Leuven/Belgique (2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Antiviral research; ISSN 0166-3542; Coden ARSRDR; Pays-Bas; Da. 2008; Vol. 78; No. 1; Pp. 47-50; Bibl. 3/4 p.</SO>
<LA>Anglais</LA>
<EA>Emerging and re-emerging pathogens and bioterror threats require an organized and coherent response from the worldwide research community to maximize available resources and competencies with the primary goals to understand the pathogen and enable intervention. In 2001, the Structural Proteomics In Europe (SPINE) project prototyped the pan-viral structural genomic approach, and the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 accelerated the concept of structural characterization of all proteins from a viral proteome and the interaction with their host partners. Following that approach, in 2004 the center for Functional and Structural Proteomics for SARS-CoV related proteins was initiated as part of the US NIH NIAID proteomics resource centers. Across worldwide efforts in Asia, Europe and America, the international research teams working on SARS-CoV have now determined experimental structural information for 45% of the SARS-CoV proteins and 53% of all its soluble proteins. This data is fully available to the scientific community and is providing an unprecedented level of insight to this class of RNA viruses. The efforts and results by the international scientific community to the SARS outbreak are serving as an example and roadmap of a rapid response using modem research methods.</EA>
<CC>002B02S05; 002B05C02C</CC>
<FD>Réseau international; Protéomique; Relation structure activité; Syndrome respiratoire aigu sévère; Virus syndrome respiratoire aigu sévère; Génomique; Virus à ARN; Recherche et développement; Antiviral; Projet Vizier</FD>
<FG>Virose; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Pathologie de l'appareil respiratoire; Pathologie des poumons</FG>
<ED>International network; Proteomics; Structure activity relation; Severe acute respiratory syndrome; Severe acute respiratory syndrome virus; Genomics; RNA virus; Research and development; Antiviral</ED>
<EG>Viral disease; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Respiratory disease; Lung disease</EG>
<SD>Red internacional; Proteómica; Relación estructura actividad; Síndrome respiratorio agudo severo; Severe acute respiratory syndrome virus; Genómica; Virus con RNA; Investigación desarrollo; Antiviral</SD>
<LO>INIST-18839.354000172642930040</LO>
<ID>08-0296266</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000277 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000277 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:08-0296266 |texte= International research networks in viral structural proteomics : Again, lessons from SARS }}
This area was generated with Dilib version V0.6.33. |